MARY RUDZEWICK: Open Payments
NPI 1376702399 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 11 payments from 9 companies in 2025. Trend: 2023 $439 · 2024 $130 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $242 |
| Astellas Pharma US Inc | 2 | $62 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Syndax Pharmaceuticals, Inc. | 1 | $26 |
| Geron Corporation | 1 | $25 |
| SOBI, INC | 1 | $23 |
| PharmaEssentia USA Corporation | 1 | $23 |
| TAIHO ONCOLOGY, INC. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: OPDIVO, Cresemba, KEYTRUDA, REVUFORJ, RYTELO, Doptelet, BESREMI, LONSURF.
Industry payments across NY — which companies pay providers there.
